Market Exclusive

Analyst Upgrades – CVS Health (NYSE:CVS) Stock Gets Upgraded By Needham & Company LLC from Buy to Strong-Buy

Analyst Ratings For CVS Health (NYSE:CVS)

Today, CVS Health (NYSE:CVS) stock received an upgrade by Needham & Company LLC from Buy to Strong-Buy with a price target of $100.00.

Some recent analyst ratings include

Dividend information for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) pays an annual dividend of $2.00 with a yield of 2.53% and an average dividend growth of 22.10% based on a 3 Year Average..

Dividend History for CVS Health (NYSE:CVS)

Recent Insider Trading Activity For CVS Health (NYSE:CVS)
CVS Health (NYSE:CVS) has insider ownership of 0.61% and institutional ownership of 81.64%.

Recent Trading Activity for CVS Health (NYSE:CVS)
Shares of CVS Health closed the previous trading session at with 78.48999786376953 shares trading hands.

Exit mobile version